Terms: = Liver cancer AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2
33 results:
1. Cryptogenic non-cirrhotic HCC: Clinical, prognostic and immunologic aspects of an emerging HCC etiology.
Beudeker BJB; Guha R; Stoyanova K; IJzermans JNM; de Man RA; Sprengers D; Boonstra A
Sci Rep; 2024 Feb; 14(1):4302. PubMed ID: 38383695
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the ddx3x-mediated NLRP3 inflammasome in hepatocellular carcinoma.
Kim Y; Jung KY; Kim YH; Xu P; Kang BE; Jo Y; Pandit N; Kwon J; Gariani K; Gariani J; Lee J; Verbeek J; Nam S; Bae SJ; Ha KT; Yi HS; Shong M; Kim KH; Kim D; Jung HJ; Lee CW; Kim KR; Schoonjans K; Auwerx J; Ryu D
Drug Resist Updat; 2024 Mar; 73():101054. PubMed ID: 38277756
[TBL] [Abstract] [Full Text] [Related]
3. Hepatocyte ddx3x protects against drug-induced acute liver injury via controlling stress granule formation and oxidative stress.
Luo T; Yang S; Zhao T; Zhu H; Chen C; Shi X; Chen D; Wang K; Jiang K; Xu D; Cheng M; Li J; Li W; Xu W; Zhou L; Jiang M; Xu B
Cell Death Dis; 2023 Jul; 14(7):400. PubMed ID: 37407573
[TBL] [Abstract] [Full Text] [Related]
4. Perturbation Analysis of a Prognostic
Lin TC
Cells; 2023 Jun; 12(12):. PubMed ID: 37371098
[TBL] [Abstract] [Full Text] [Related]
5. Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling.
Liu S; Chen X; Huang K; Xiong X; Shi Y; Wang X; Pan X; Cong Y; Sun Y; Ge L; Xu J; Jia X
Exp Cell Res; 2023 Jan; 422(2):113438. PubMed ID: 36435219
[TBL] [Abstract] [Full Text] [Related]
6. PRR34-AS1 promotes exosome secretion of VEGF and TGF-β via recruiting ddx3x to stabilize Rab27a mRNA in hepatocellular carcinoma.
Zhang Z; Zhou Y; Jia Y; Wang C; Zhang M; Xu Z
J Transl Med; 2022 Oct; 20(1):491. PubMed ID: 36303180
[TBL] [Abstract] [Full Text] [Related]
7. Identification of hepatocellular carcinoma and paracancerous tissue based on the peak area in FTIR microspectroscopy.
Peng W; Yin J; Ma J; Zhou X; Chang C
Anal Methods; 2022 Aug; 14(32):3115-3124. PubMed ID: 35920728
[TBL] [Abstract] [Full Text] [Related]
8. Organ doses and cancer risk assessment in patients exposed to high doses from recurrent CT exams.
Zewde N; Ria F; Rehani MM
Eur J Radiol; 2022 Apr; 149():110224. PubMed ID: 35217250
[TBL] [Abstract] [Full Text] [Related]
9. Factors associated with liver cancer prognosis after hepatectomy: A retrospective cohort study.
Yuan Y; Yang F; Wang Y; Guo Y
Medicine (Baltimore); 2021 Oct; 100(42):e27378. PubMed ID: 34678864
[TBL] [Abstract] [Full Text] [Related]
10. Stimulating ddx3 expression by serotonin 5-HT receptor 7 through phosphorylation of p53 via the AC-PKA-ERK signaling pathway.
Kang LJ; Nguyen KVA; Eom S; Choi YJ; Nguyen CN; Lee J; Kim C; Lee S; Lee SG; Lee JH
J Cell Biochem; 2019 Oct; 120(10):18193-18208. PubMed ID: 31172579
[TBL] [Abstract] [Full Text] [Related]
11. Rottlerin upregulates ddx3 expression in hepatocellular carcinoma.
Wang Z; Shen GH; Xie JM; Li B; Gao QG
Biochem Biophys Res Commun; 2018 Jan; 495(1):1503-1509. PubMed ID: 29203243
[TBL] [Abstract] [Full Text] [Related]
12. ddx3 regulates endoplasmic reticulum stress-induced ATF4 expression.
Adjibade P; Grenier St-Sauveur V; Bergeman J; Huot ME; Khandjian EW; Mazroui R
Sci Rep; 2017 Oct; 7(1):13832. PubMed ID: 29062139
[TBL] [Abstract] [Full Text] [Related]
13. ddx3 Represses Stemness by Epigenetically Modulating Tumor-suppressive miRNAs in Hepatocellular Carcinoma.
Li HK; Mai RT; Huang HD; Chou CH; Chang YA; Chang YW; You LR; Chen CM; Lee YH
Sci Rep; 2016 Jun; 6():28637. PubMed ID: 27344963
[TBL] [Abstract] [Full Text] [Related]
14. ddx3, a potential target for cancer treatment.
Bol GM; Xie M; Raman V
Mol Cancer; 2015 Nov; 14():188. PubMed ID: 26541825
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Factors after liver Resection for Colorectal liver Metastasis.
Matias M; Casa-Nova M; Faria M; Pires R; Tato-Costa J; Ribeiro L; Costa L
Acta Med Port; 2015; 28(3):357-69. PubMed ID: 26421789
[TBL] [Abstract] [Full Text] [Related]
16. ddx3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract] [Full Text] [Related]
17. Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases.
Upadya MH; Aweya JJ; Tan YJ
World J Gastroenterol; 2014 Mar; 20(11):2913-26. PubMed ID: 24659882
[TBL] [Abstract] [Full Text] [Related]
18. Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells.
Ghasemi R; Ghaffari SH; Momeny M; Pirouzpanah S; Yousefi M; Malehmir M; Alimoghaddam K; Ghavamzadeh A
Nutr Cancer; 2013; 65(4):590-9. PubMed ID: 23659451
[TBL] [Abstract] [Full Text] [Related]
19. Can tobacco use promote HCV-induced miR-122 hijacking and hepatocarcinogenesis?
Zhao L; Li F; Taylor EW
Med Hypotheses; 2013 Feb; 80(2):131-3. PubMed ID: 23218444
[TBL] [Abstract] [Full Text] [Related]
20. Promotion of hepatocellular carcinoma by hepatitis C virus.
Bühler S; Bartenschlager R
Dig Dis; 2012; 30(5):445-52. PubMed ID: 23108300
[TBL] [Abstract] [Full Text] [Related]
[Next]
